Boston Scientific Corporation vs Pfizer, Inc. — Stock Comparison

BSX
Boston Scientific Corporation
$56.50
▼ 1.93%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Boston Scientific Corporation
BSX8.7/10vs 6.5/10

Q·Score Breakdown

8.7
Very Bullish
Overall
6.5
Neutral
7.7
Quality
7.4
9.1
Health
7
8.8
Growth
5.6
9.1
Valuation
6.7
9
Sentiment
5.2
BSX

Clean balance sheet with low leverage (0.4× debt-to-equity).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $85.19 (+50.8%)
32 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

BSX
PFE
23.6×
Trailing P/E
19.4×
15.0×
Forward P/E
9.4×
17.3%
Profit Margin
12.4%
68.9%
Gross Margin
75.8%
14.7%
ROE
8.9%
11.6%
Revenue Growth
-1.2%
100.0%
Earnings Growth
0.78
Beta
0.39
Price / Book
$84.0B
Market Cap
$149.8B
$56 – $110
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →